Lacosamide Arrow

Lacosamide, the active ingredient in Lacosamide Arrow, is an anticonvulsant presented as an oral tablet for oral use. It treats partial‑onset seizures and epilepsy in adults and children who require adjunctive therapy.

GNH USA supplies Lacosamide Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide Arrow is an anticonvulsant indicated for seizure disorders and related neurological conditions. - Partial‑onset seizures: reduces seizure frequency when used as add‑on therapy. - Epilepsy (adjunctive treatment): helps achieve better overall seizure control. - Refractory focal epilepsy: provides an alternative mechanism for patients not responding to other agents.

Lacosamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient light‑headedness, especially after dose initiation. - Nausea: mild gastrointestinal upset, often resolves with continued use. - Headache: mild to moderate intensity, may improve over time. - Fatigue: feeling unusually tired or weak. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Cardiac conduction abnormalities: PR‑interval prolongation or arrhythmias. - Suicidal ideation: new or worsening thoughts of self‑harm. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hypersensitivity: rash, angioedema, or anaphylaxis. - Hepatic enzyme elevation: significant increase in liver function tests. - Respiratory depression: especially when combined with other CNS depressants.

Before initiating therapy, consider the following safety measures. - Renal impairment: adjust dose if significant renal dysfunction is present. - Hepatic impairment: monitor liver function and consider dose modification. - Cardiac conduction disorders: obtain baseline ECG and monitor PR interval. - Pregnancy: safety not established; discuss risks with a healthcare professional. - Driving and operating machinery: caution until individual response is known. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lacosamide can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase lacosamide plasma levels. - Strong CYP3A4 inducers (e.g., rifampicin): may reduce lacosamide effectiveness. - Other sodium‑channel blockers (e.g., carbamazepine, phenytoin): increase risk of cardiac conduction effects.

Moderate Interactions (Monitor Closely): - Oral contraceptives: lacosamide may reduce hormonal efficacy; consider alternative contraception. - Co‑administered antiepileptics: dose adjustments may be needed to maintain seizure control. - Alcohol: may enhance central nervous system depression, leading to increased drowsiness.